首页> 外国专利> Boron uptake in tumors, cerebrum and blood from 10B!NA4B24H22S2

Boron uptake in tumors, cerebrum and blood from 10B!NA4B24H22S2

机译:10B!NA4B24H22S2从肿瘤,大脑和血液中吸收硼

摘要

A stable boronated (.sup.10 B-labeled) compound, sodium mercaptoundecahydrododecaborate is infused in the form of the disulfide dimer, .sup.10 B!Na.sub.4 B.sub.24 H.sub.22 S.sub.2, at a dose of about 200 &mgr;g .sup.10 B per gm body weight. The infusion is performed into the blood or peritoneal cavity of the patient slowly over a period of many days, perhaps one week or more, at the rate of roughly 1 &mgr;g .sup. 10 B per gm body weight per hour. Use of this particular boronated dimer in the manner or similarly to the manner so described permits radiotherapeutically effective amounts of boron to accumulate in tumors to be treated by boron neutron capture radiation therapy and also permits sufficient retention of boron in tumor after the cessation of the slow infusion, so as to allow the blood concentration of .sup.10 B to drop or to be reduced artificially to a radiotherapeutically effective level, less than one-half of the concentration of .sup.10 B in the tumor.
机译:稳定的硼化(乙10硼标记)化合物巯基十二氢十二硼酸钠以二硫化物二聚体乙10 Na 4乙24 H 22亚22的形式注入。 .2,每克体重约200 mg·s 10 B的剂量。在数天的时间里,可能是一周或更长的时间内,以大约1微克的速率缓慢地向患者的血液或腹膜腔内输注。每小时每克体重10B。以这种方式或与所描述的方式类似的方式使用这种特定的硼化二聚体可以使放射治疗有效量的硼积累在要通过硼中子俘获放射疗法治疗的肿瘤中,并且还允许在缓慢停止后将硼充分保留在肿瘤中。输注,以使10 B的血液浓度下降或被人为降低至放射治疗有效水平,小于肿瘤中10 B浓度的一半。

著录项

  • 公开/公告号USH505H

    专利类型

  • 公开/公告日1988-08-02

    原文格式PDF

  • 申请/专利权人

    申请/专利号US19860838494

  • 申请日1986-03-11

  • 分类号A61N5/12;A61K43/00;A61K41/00;

  • 国家 US

  • 入库时间 2022-08-22 06:48:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号